Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
From Research to Clinical Practice: Evidence-Based Pharmacogenomic Recommendations
Track:
Educational Sessions (CE)
Program Code: 252-L04
Date: Tuesday, December 8, 2009
Time: 4:00 PM to 5:00 PM EST
Location:
Palazzo M, Level 5
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Grace Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Grace Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego Joseph Ma, PharmD, Assistant Professor, University of California, San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences
Description
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists Taskforce on Science
ACPE Activity #204-000-09-252-L04P
1.0 Contact Hour / Knowledge-based
Educational Content: Level 2
Moderator: Grace M. Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla
4:00 p.m. – 4:05 p.m.
Announcements and Introduction
4:05 p.m. – 4:30 p.m.
Pharmacogenomic Recommendations in Therapeutic Areas
Joseph D. Ma, PharmD, Assistant Professor, University of California, San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences, San Diego
4:30 p.m. – 4:50 p.m.
Pharmacogenomic Recommendations in Therapeutic Areas
Grace M. Kuo
4:50 p.m. – 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-252-L04P
1.0 Contact Hour / Knowledge-based
Educational Content: Level 2
Moderator: Grace M. Kuo, PharmD, MPH, Associate Professor of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences; and Associate Professor of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla
4:00 p.m. – 4:05 p.m.
Announcements and Introduction
4:05 p.m. – 4:30 p.m.
Pharmacogenomic Recommendations in Therapeutic Areas
Joseph D. Ma, PharmD, Assistant Professor, University of California, San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences, San Diego
4:30 p.m. – 4:50 p.m.
Pharmacogenomic Recommendations in Therapeutic Areas
Grace M. Kuo
4:50 p.m. – 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
LEARNER OUTCOMES:
- Compare the risks and benefits of pharmacogenomic testing for a medication based upon primary literature evidence.
- For each therapeutic area, identify the pharmacogenomic testing that is available to determine therapeutic or toxic outcomes for a medication.
- Identify key therapeutic areas in which pharmacogenomic testing can be applied in the clinical setting.
- Summarize the recommendations for pharmacogenomic testing based upon recommendations from the Evaluation of Genomic Applications in Practice and Prevention (EGAPP), other agencies (e.g. FDA), and published literature.
- Using patient case scenarios, formulate a plan for pharmacogenomic testing based upon available scientific evidence, ethical issues, and feasibility.
This session is a part of:
Handout Online
